Michael Hayden

Michael Hayden

Founder bij 89BIO, INC.

Vermogen: 12 M $ op 29-02-2024

72 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Michael R.
Hayden
is an entrepreneur who founded 7 companies, including: Xenon Pharmaceuticals, Inc., Aspreva Pharmaceuticals Corp.
and 89bio, Inc. Currently, he occupies the position of Chief Executive Officer & Director at Prilenia Therapeutics BV (which he founded in 2018), Scientific Director at Canadian Genetics Diseases Network, Venture Partner at Forbion Capital Partners Management Holding BV and Venture Advisor at Andera Partners SCA.
Dr. Hayden is also Director-Translational Laboratory at National University of Singapore, Professor at the University of British Columbia, Member of American Society of Clinical Investigation and Director & Program Director at Translational Laboratory in Genetic Medicine and on the board of 5 other companies.
In the past Michael R.
Hayden
held the position of President & Chief Scientific Officer at GlobaR&D Co.,Ltd, Chief Scientific Officer at Teva Pharmaceutical Industries Ltd., Independent Director at Xenon Pharmaceuticals, Inc. (he founded the company in 1996), Director at American Society of Human Genetics, Director at Aspreva Pharmaceuticals Corp.
and Director at Centre for Molecular Medicine & Therapeutic.
He received an undergraduate degree and a doctorate from the University of Cape Town.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
22-09-2023 1 441 642 ( 0.49% ) 7 M $ 29-02-2024
01-02-2024 246 430 ( 0.27% ) 3 M $ 29-02-2024
17-07-2023 32 219 ( 0.02% ) 1 M $ 29-02-2024
13-11-2023 39 973 ( 0.04% ) 86 970 $ 29-02-2024

Actieve functies van Michael Hayden

BedrijvenFunctieBegin
IONIS PHARMACEUTICALS, INC. Director/Board Member 24-09-2018
89BIO, INC. Founder 01-04-2018
ABCELLERA BIOLOGICS INC. Director/Board Member 01-10-2019
OXFORD BIOMEDICA PLC Director/Board Member 15-07-2021
Consultant / Advisor 01-01-2018
Private Equity Investor 31-03-2022
Founder 01-10-2018
National University of Singapore Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal 01-01-1992
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Alle actieve functies van Michael Hayden

Eerdere bekende functies van Michael Hayden

BedrijvenFunctieEinde
░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Ervaring van Michael Hayden in detail bekijken

Opleiding van Michael Hayden

University of Cape Town Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Michael Hayden in detail bekijken

Connecties

100 +

Eerstegraads connecties

27

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven8
TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Health Technology

IONIS PHARMACEUTICALS, INC.

Health Technology

OXFORD BIOMEDICA PLC

Health Technology

XENON PHARMACEUTICALS INC.

Health Technology

MANY BRIGHT IDEAS TECHNOLOGIES INC.

Health Services

AURINIA PHARMACEUTICALS INC.

Health Technology

ABCELLERA BIOLOGICS INC.

Health Technology

89BIO, INC.

Health Technology

Bedrijven in privébezit16

Health Technology

Health Technology

Finance

Commercial Services

Finance

Miscellaneous

Commercial Services

American Society of Clinical Investigation

Commercial Services

Commercial Services

Centre for Molecular Medicine & Therapeutic

Health Technology

Translational Laboratory in Genetic Medicine

Commercial Services

Health Technology

GlobaR&D Co. ,Ltd

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Michael Hayden